About us - What we do
WE ARE PHARMA INDUSTRY CONSULTANTS WHO LEAD WITH VISION AND DELIVER IN THE FIELD.
ABOuT US - OUR VALUES
AT “DRUGS2MARKET”, WE ARE EXPERT CONSULTANTS DRIVEN BY A SHARED PASSION FOR SUCCESS.
OUR MARKETS IN FOCUS
WE ARE ALL PARTICULARLY MEANT AND DEDICATED TO SUPPORT INDIAN, CHINESE, JAPANESE & SOUTH KOREAN GROUPS TO NAVIGATE THE EUROPEAN COMPLEXITY.
Our Services
PRODUCT LAUNCH OPTIMIZATION
Launching a new drug is a complex process that involves a significant number of departments and people. It requires coordinating a very large number of tasks in a precise order. Anticipating, coordinating, and synchronizing these respective contributions is essential to avoid delays in market launch and ensure a return on investment (ROI).





















Our methodology
BE FOCUSED AND DELIVER
Our focus is to identify the highest-impact levers aligned with Board’s strategic priorities to accelerate time-to-market and deliver measurable, business-critical results. Pick and choose the service your organization needs.
01 - Tailor made, Customized & Agile approach
We adapt our methods to your unique context, challenges, and strategic priorities - ensuring relevance and impact at every step
- Agile methods tailored to your unique environment
- Aligned to your strategy, challenges, and operational context
- Designed to deliver real-commercial impact
02 - Driven by data. Grounded in Insights.
We do:
- In-depth desk market analysis of your data and reports
- Field operational market analysis
- End customers (physicians, pharmacists, patients)
- Regulatory
- Price & Reimbursement bodies
- Identify key success factors and challenges
- Align on strategic goals & forecasting
03 - Diagnostics
You get:
- Customed diagnostics based on industry benchmarks
- Clear brand positioning and image
- A solid foundation for strategic planning
- Forecasting
- Clear, actionable insights for regulatory and marketing
04 - From Strategy to Execution
- We do:
- Plan for filing or pricing
- List the best tools from sales to multi-channel
- Develop promotional assets
- Develop medical training
- Train the sales force
05 - Always Adapting, Always Moving Forward
- Agile monitoring of program progress
- Adaptive response to hurdles and changes
- Continual refinement to meet targets
06 - Empowering Teams Through Skill Transfer
- Hands-on coaching, knowledge transfer is part of every engagement
Pure Professional and 100% all round support /driver / strategic insight for the business. Strong leadership, taking projects in hands to improve the overall business. Always looking for ways to further boost sales and patient support. Marie-France, you are one of Europe’s driving forces.
Riccardo Todaro, 2024, Country Manager and cluster lead France – Benelux
Biocon BiologicsThe knowledge and hands on experience is second to none. Knowledge sharing, understanding the specific market needs, finding innovative solutions in a manner that all stakeholders can appreciate and align with
Karan Cariappa, 2024, Head of strategic Programs – Emerging markets.
Biocon BiologicsI have enjoyed working together with Marie-France, you are a great team player, always engaged and responsive. Your ability to push for solutions in a respectful and collaborative manner makes working with you and the team you lead a genuine pleasure. I’m also very impressed with the way you push the team and extended team to go beyond and take risks. Thanks for the collaboration and hard work
Rahul Kapur, 2024, VP and Head – Medical Affairs, Patient Value
Biocon BiologicsStrong understanding of the markets, great strides in developing new process, roles & responsibilities. Readily available to problem solving which is especially important during start up phase. Developed and maintained strong relationships across the organization.
Stephanie Wasco, 2024, Senior Vice President and Head of Communications, Advanced markets
Biocon BiologicsInvaluable and experience partner, known for her balanced and decisive decision making. Consistently played a pivotal role in achieving our goals, notable in the successful launches of Hulio and Nepexto. Expertise and dedication have been instrumental, thanks for this. We now have effective tender process in place. Contribution deeply appreciated.
Hugo M. Carradinha, 2024, Cluster lead Mediterranean countries
Biocon BiologicsNew ideas and open mind to the biologics business, including full patient support program and concept to engage and drive business with Key customers. Thank you for always taking the extra mile, highly appreciated! Hulio performance in BE is the best in the biosimilar group.
Artur Cwiok, 2020, Head of Europe
ViatrisI was able to appreciate the expertise in marketing, both for OTC products and prescription drugs. Good relationships with the medical community and specialists help to clearly define product positioning. Experience with major companies allows for delivering added value to many pharmaceutical firms.




